Patent · US Active

Device for sterile uterine sampling and drug delivery

US9730679B1 · kind B1 · utility

2Cited by
18References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 20, 2013
Grant dateAug 15, 2017
Priority date
Expiry dateJul 5, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A device and method for the collection of sterile specimen samples from the uterus is presented. Also presented is a method of delivering nano-encapsulated drugs to the female reproductive tract to treat pelvic inflammatory disease. The device generally is comprised of an outer cannula over which a cover is provided. A sampler may be positioned within the cannula so that when the sampler is advanced through the cannula, the sampler exits an orifice at one end of the cannula and pierces the cover causing it to retract. In use, the device is positioned within the vagina and once correctly positioned, the sampler is advanced thus piercing the cover and allowing an uncontaminated sample to be taken from the uterus or a drug to be delivered directly into the uterus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.